EXHIBIT 99.1

ATRION CORPORATION
ONE ALLENTOWN PARKWAY
ALLEN, TEXAS  75002


                                                                         ATRION
                                                                   NEWS RELEASE

FOR IMMEDIATE RELEASE

                  ATRION CORPORATION TO COMMENCE TENDER OFFER
                  FOR UP TO 500,000 SHARES OF ITS COMMON STOCK

     ALLEN, Texas (November 21, 2001) - Atrion Corporation (Nasdaq/NM-ATRI)
announced today that it plans to commence an issuer tender offer to purchase
for cash up to 500,000 shares of its issued and outstanding common stock, par
value $.10 per share. The tender offer is expected to begin on Monday, November
26, 2001 and to expire, unless extended, at 12:00 Midnight, New York City time,
on Friday, December 21, 2001.

     Terms of the tender offer, which will be described more fully in the Offer
to Purchase and Letter of Transmittal, invite the Company's stockholders to
tender up to 500,000 shares of the Company's common stock to the Company at a
price of $34.50 per share. The offer is subject to certain conditions. The
Company will, subject to the terms and conditions of the offer, purchase
500,000 shares (or such lesser number of shares as are validly tendered and not
withdrawn) pursuant to the offer. Shares tendered and not purchased because of
proration will be returned at the Company's expense. The Company reserves the
right, in its sole discretion, to purchase more than 500,000 shares pursuant to
the offer. The closing sales price of the Company's common stock on November
20, 2001 as reported by Nasdaq was $32.0247 per share.

     Atrion Corporation designs, develops, manufactures, sells and distributes
medical products and components to markets worldwide.

                                      ###

     This press release is for informational purposes only and is not an offer
to buy or the solicitation of an offer to sell any shares of the Company's
common stock. The offer to buy will only be made by the Offer to Purchase and
related materials that the Company will be sending to its stockholders shortly.
Stockholders are advised to read those materials when they become available
because they will contain important information, including the various terms
and conditions of the offer. Stockholders will also be able to obtain for free
copies of the Offer to Purchase and related materials at the SEC's website at
www.sec.gov or from the Company's information agent, Innisfree M&A
Incorporated, at 501 Madison Avenue, 20th Floor, New York, New York 10022,
telephone: (888) 750-5834.


Contact: Jeffery Strickland
         Vice President and Chief Financial Officer
         (972) 390-9800

                                    - END -